Results 121 to 130 of about 6,333 (188)

Chronic Kidney Disease (CKD): Systematic Review of the Cost Effectiveness of SGLT2 Inhibitors and Other Novel Nephroprotective Drugs. [PDF]

Pharmacoeconomics
Darbà J, Ascanio M, Rodríguez A.
europepmc   +1 more source

Lifetime Effects of Adherence to Cardiovascular and Diabetes Medications in Spain: A Modelling Study in a Population Cohort of 152,117 Patients. [PDF]

Pharmacoeconomics
Sánchez-Viñas A, Wu R, Aznar-Lou I, Mihaylova B, Rubio-Valera M.   +4 more
europepmc   +1 more source

Economic evidence on provider-level implications of direct posterior amalgam alternatives following the EU phase-out: a scoping review. [PDF]

BMJ Open
Oesterreicher J, Herz MM.
europepmc   +1 more source

Analysing Biases in Genealogies Using Demographic Microsimulation. [PDF]

Eur J Popul
Calderón-Bernal LP, Alburez-Gutierrez D, Zagheni E.   +2 more
europepmc   +1 more source

Impact of the national steps challenge physical activity programme on obesity and type 2 diabetes prevalence in Singapore to 2050: simulation-based forecasting analysis. [PDF]

Lancet Reg Health West Pac
Normatov B, Song H, Jin S, Zhang X, He Y, Lim NWH, Zheng VF, Bin Mohd Aziz MH, Müller-Riemenschneider F, Ling Lee CP, Dickens BL.   +10 more
europepmc   +1 more source

Simulating COVID-19 lockdowns' impact on depressive symptoms in the northern Netherlands. [PDF]

BMC Public Health
Thompson K, Kaan J, Qi J, Pham AA, Viviani E.   +4 more
europepmc   +1 more source

Projected Oral Health Outcomes and Costs Associated With Pediatric Medicaid Disenrollment.

JAMA Netw Open
Choi SE, Simon L, Hayes C, Giannobile WV.   +3 more
europepmc   +1 more source

The cost of non-drug interventions that improve function and reduce dementia-related behaviors. [PDF]

BMC Geriatr
Jutkowitz E, Pizzi LT, Shewmaker P, Alarid-Escudero F, Epstein-Lubow G, Gaugler JE, Gitlin LN.   +6 more
europepmc   +1 more source